While PAD2 inhibitor followed by PAD3 inhibitor had the most effects on reducing cancer cell invasion, elevating moesin expression, and modulating EV signatures in the PDAC cells in the current study, PAD4 inhibitor had negligible effects and pan-PAD inhibitor Cl-amidine was also less effective. Here, PADI2 is linked to cancer.